The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Galenica Forward PE Ratio Related Terms
Galenica Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Galenica's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galenica Forward PE Ratio Chart
Galenica Annual Data
Trend
2018-12
2019-12
2020-12
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
16.34
21.10
20.49
19.57
20.92
20.16
20.31
24.33
Galenica Semi-Annual Data
2018-06
2018-12
2019-06
2019-12
2020-06
2020-12
2021-06
2021-12
2022-06
2022-12
2023-06
2023-12
2024-12
2025-06
2025-12
Forward PE Ratio
21.69
16.34
18.66
21.10
22.47
20.49
21.65
19.57
21.37
20.92
20.37
20.16
20.31
23.75
24.33
XSWX:GALE vs MCK, CAH, COR: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Galenica's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Galenica's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Galenica (XSWX:GALE) has a Forward PE Ratio of 22.00 as of Jul. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Galenica and its competitors. According to the industry distribution chart, Galenica ranks #43 out of 51 companies in the Medical Distribution industry, placing it in the top 84.3%.
Is Galenica's Forward PE Ratio too high?
Galenica's current Forward PE Ratio is 22.00. The Medical Distribution industry median Forward PE Ratio is 14.57. Galenica's value of 22.00 is 51% above this industry median. Based on the distribution chart, Galenica ranks #43 out of 51 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Galenica has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Galenica's Forward PE Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Galenica ranks #43 out of 51 companies for Forward PE Ratio. This places Galenica in the lower half of its industry. The industry median Forward PE Ratio is 14.57. Galenica's value of 22.00 is 51% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.57, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current Forward PE Ratio of 22.00 is 51% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current Forward PE Ratio is 22.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Based on GuruFocus' analysis, Galenica (XSWX:GALE) is currently considered Fairly Valued. The stock's GF Value™ is CHF86.08, compared to a current price of CHF86.75 — trading 0.8% above its estimated fair value. The current Forward PE Ratio is 22.00 and 51% above the Medical Distribution industry median of 14.57. Galenica's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Galenica (XSWX:GALE), the current Forward PE Ratio is 22.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (XSWX:GALE) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be overvalued.
The current stock price of CHF86.75 is trading 0.8% above its estimated GF Value™ of CHF86.08.
GuruFocus considers Galenica to be Fairly Valued.
Key valuation signals for XSWX:GALE:
Forward PE Ratio: 22.00
GF Value™: CHF86.08 vs. price of CHF86.75 (0.8% above fair value)
Industry Position: 51% above the Medical Distribution median (#43 of 51)
No single metric tells the full story. See the XSWX:GALE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
81GF Score
Get the complete analysis for XSWX:GALE
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GALE has been successfully added to your 